Of particular interest has been HML-2 proviral expression in diseased tissues associated with breast cancer, with up-regulation of HML-2 both from breast tumor biopsies and cell lines derived from breast tumor tissues [41,43–48]. The gene discussed is CLEC10A; the disease is breast carcinoma.